PAOLIERI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 294
EU - Europa 232
AS - Asia 70
AF - Africa 34
OC - Oceania 1
Totale 631
Nazione #
US - Stati Uniti d'America 294
IT - Italia 119
SE - Svezia 70
CN - Cina 40
CI - Costa d'Avorio 22
SG - Singapore 18
BG - Bulgaria 16
GB - Regno Unito 12
SN - Senegal 9
DE - Germania 8
VN - Vietnam 7
IN - India 3
NG - Nigeria 3
AT - Austria 2
HK - Hong Kong 2
IE - Irlanda 2
AU - Australia 1
FI - Finlandia 1
FR - Francia 1
PL - Polonia 1
Totale 631
Città #
Milan 53
Chandler 52
Fairfield 35
Ashburn 24
Abidjan 22
Cambridge 22
Woodbridge 21
Seattle 18
Sofia 16
Wilmington 16
Florence 13
Ann Arbor 11
Houston 11
London 11
Pisa 11
Beijing 10
New York 10
Dakar 9
Princeton 9
Lawrence 8
Guangzhou 7
Rome 6
Dong Ket 5
Medford 4
Bremen 3
Chiesina Uzzanese 3
Dallas 3
Frankfurt am Main 3
Lagos 3
San Diego 3
Shenzhen 3
Fuzhou 2
Hebei 2
Hong Kong 2
Nanjing 2
Palermo 2
Vienna 2
Xian 2
Bologna 1
Des Moines 1
Garden City 1
Genoa 1
Hangzhou 1
Lappeenranta 1
Leawood 1
Melbourne 1
Napoli 1
Paris 1
Pelago 1
Pietrasanta 1
Pune 1
Reggio Nell'emilia 1
Shenyang 1
Stockholm 1
Wandsworth 1
Warsaw 1
Wuhan 1
Totale 458
Nome #
Dedifferentiated liposarcoma: when eribulin can make the difference 101
AR-V7 and AR-FL expression is associated with clinical outcome: a translational study in patients with castrate resistant prostate cancer 99
Effectiveness of Multi-Prognostic Index in older patients with advanced malignancies treated with immunotherapy 90
Multi-dimensional scaling analysis of key regulatory genes in prostate cancer using the tcga database 82
Neoplasie degli organi emopoietici e linfatici: peculiarità dell'anziano 79
Clinical and economic effect of administration of red blood product transfusions in an outpatient supportive care cancer service 70
1711P SARS-CoV-2 infection in prostate cancer patients: Data from a high-incidence area in Italy 51
CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone 50
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs 25
Totale 647
Categoria #
all - tutte 2.227
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.227


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 1 3
2019/2020104 1 6 0 3 5 17 16 13 16 11 10 6
2020/202176 5 6 0 5 0 8 14 0 13 5 12 8
2021/2022134 1 2 2 3 55 29 4 5 6 1 7 19
2022/2023196 17 31 14 7 23 18 3 11 54 1 15 2
2023/2024133 16 26 25 14 22 13 7 3 2 1 4 0
Totale 647